Comparative effectiveness of colony-stimulating factors for febrile neutropenia: a retrospective study.
about
Risk and consequences of chemotherapy-induced neutropenic complications in patients receiving daily filgrastim: the importance of duration of prophylaxis.Kinetics of neutrophils in mice exposed to radiation and/or granulocyte colony-stimulating factor treatment.A randomized, double-blind, active control, multicenter, dose-finding study of lipegfilgrastim (XM22) in breast cancer patients receiving myelosuppressive therapy.Pegfilgrastim prophylaxis is associated with a lower risk of hospitalization of cancer patients than filgrastim prophylaxis: a retrospective United States claims analysis of granulocyte colony-stimulating factors (G-CSF)Efficacy, effectiveness and safety of long-acting granulocyte colony-stimulating factors for prophylaxis of chemotherapy-induced neutropenia in patients with cancer: a systematic review.Comparative effectiveness of granulocyte colony-stimulating factors to prevent febrile neutropenia and related complications in cancer patients in clinical practice: A systematic review.Multicentre, Prospective Observational Study of Pegfilgrastim Primary Prophylaxis in Patients at High Risk of Febrile Neutropenia in Poland: PROFIL StudyReal-world impact of granulocyte-colony stimulating factor on febrile neutropeniaThe use of granulocyte colony-stimulating factors in a Canadian outpatient setting.Optimal use of recombinant granulocyte colony-stimulating factor with chemotherapy for solid tumors.Pegfilgrastim: a review of the pharmacoeconomics for chemotherapy-induced neutropenia.Comparative effectiveness of colony-stimulating factors in febrile neutropenia prophylaxis: how results are affected by research design.A retrospective study of patients' out-of-pocket costs for granulocyte colony-stimulating factors.Pegfilgrastim for the prevention of chemotherapy-induced febrile neutropenia in patients with solid tumors.Burden of Chemotherapy-Induced Febrile Neutropenia Hospitalizations in US Clinical Practice, by Use and Patterns of Prophylaxis with Colony-Stimulating Factor.Increasing utilization and predictors of hematopoietic growth factors in patients diagnosed with colorectal cancer: findings from a large national population-based cohort in the USA, 1992-2009.Use of pegfilgrastim primary prophylaxis and risk of infection, by chemotherapy cycle and regimen, among patients with breast cancer or non-Hodgkin's lymphoma.Risk of chemotherapy-induced febrile neutropenia by day of pegfilgrastim prophylaxis in US clinical practice from 2010 to 2015.Model-based approach to describe G-CSF effects in carboplatin-treated cancer patients.Systematic Review and Meta-analysis of Short- versus Long-Acting Granulocyte Colony-Stimulating Factors for Reduction of Chemotherapy-Induced Febrile NeutropeniaIncidence of febrile neutropenia during chemotherapy among patients with nonmyeloid cancer receiving filgrastim vs a filgrastim biosimilar
P2860
Q33602351-69F205A0-54CE-41EB-A432-0B8FF8130388Q34020253-11A631ED-8B52-49A6-A464-1A0988DF88C9Q34333814-C2E17E49-B536-4C30-8A8F-A204802FC656Q34539360-D671D220-1507-4232-B3A9-C7C82AA8FD52Q35303471-F93BC879-A3F0-4721-B119-83792B81AE53Q35894752-C316B59E-E588-4BDE-A6F6-86A779A470B5Q36243957-E4F73836-600D-4ED9-801F-2AE7495E2499Q36897773-0B900C3E-25DA-470B-902B-28F4A174F9C9Q37719624-CC39CC5E-B09C-4311-99B2-41D484891516Q37931905-4A4CB79B-2BD4-4731-8841-7540C6E45715Q38068457-7F22FFBA-AE13-4CFF-ABF6-455EFB0D2430Q38309710-75064814-2E15-43EE-9A24-AB86B228B01BQ38427936-A93B1D9D-CAA5-43DE-90A5-D5457224726EQ38613025-BE6ED8CB-FF75-4D0E-B18C-8178558873C2Q39297322-616237FE-015D-4F3F-BBEB-0576B4F42E35Q41735144-BB8FA95D-AC93-4EE5-B4B4-59636DCA34A1Q44395288-54858747-2F4A-49B4-800D-F685D63E2DFFQ47668200-68699FF5-1FFF-4E03-BF17-CDC728A2A9B5Q50878372-4ACC9CC5-DC02-461F-BBAB-8E85ACD85303Q57292845-B1532DED-EC6D-47CA-82A3-A86F00986A2BQ58767839-8F5C7F5E-F77B-4EEE-93C5-15D4C6DB288D
P2860
Comparative effectiveness of colony-stimulating factors for febrile neutropenia: a retrospective study.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Comparative effectiveness of c ...... openia: a retrospective study.
@ast
Comparative effectiveness of c ...... openia: a retrospective study.
@en
type
label
Comparative effectiveness of c ...... openia: a retrospective study.
@ast
Comparative effectiveness of c ...... openia: a retrospective study.
@en
prefLabel
Comparative effectiveness of c ...... openia: a retrospective study.
@ast
Comparative effectiveness of c ...... openia: a retrospective study.
@en
P2093
P1476
Comparative effectiveness of c ...... openia: a retrospective study.
@en
P2093
Dana Hurley
Gregory Daniel
Hiangkiat Tan
Karen Tomic
Rich Barron
P356
10.1185/03007995.2010.536527
P407
P577
2010-11-22T00:00:00Z